Last reviewed · How we verify
PYROXYLIN
At a glance
| Generic name | PYROXYLIN |
|---|---|
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Identification of Cellular Biomarkers of Rare Eye Diseases in Adults (NA)
- Evaluation of the Protection of a Liquid Bandage (NA)
- Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage (NA)
- Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infection (NA)
- Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca (PHASE4)
- Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children
- EEG@HOME (Phase 4 of the Project) (NA)
- EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PYROXYLIN CI brief — competitive landscape report
- PYROXYLIN updates RSS · CI watch RSS